Bharat Biotech's COVAXIN clinical trials begins in Rohtak, no adverse effects
18-07-2020 Sat 07:52
Hyderabad's Bharat Biotech developed COVAXIN, a vaccine candidate for Coronavirus human trials initiated on 15th July across the country on 375 volunteers. According to the sources, scientist SR Rao disclosed that the results of the clinical trial have arrived and the trials conducted in Rohtak were not showing any adverse effects. He further added that the vaccine will not come before September and it will take nearly one year to bring the vaccine.
Earlier, Bharat Biotech took to Twitter and shared as "India's First Indigenous COVID 19 Vaccine, COVAXIN™, initiated Phase-1 clinical trials across the country on 15th July 2020." Click the video for more information.
More Latest Video News
CBI speeds up investigation on YS Vivekananda Reddy case
For the last 58 days, the Central Bureau of Investigation (CBI) has been probing the murder of former minister YS Vivekananda Reddy. It has now accelerated the investigation. Following the registration of watchman Rangaiah's..
Sachin Tendulkar introduces his puppy 'Spike'
Sachin Tendulkar, the legendary batsman, has welcomed a new member to his family. Spike is the name of the puppy, which was adopted by Sachin after coming to know the sad story of it...
Night curfew in AP extended till August 14
Amaravati: The Andhra Pradesh government on Friday extended the night curfew till August 14 as positive cases are still being reported. Chief Minister YS Jagan Mohan Reddy has conducted a review meeting with top..